Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19
Closed -$761 4345
2026
Q1
$761 Buy
+19
New +$899 ﹤0.01% 3938
2025
Q4
Sell
-36
Closed -$1.61K 4349
2025
Q3
$1.61K Buy
+36
New +$1.72K ﹤0.01% 3820
2024
Q4
Sell
-21
Closed -$1K 4002
2024
Q3
$1K Hold
21
﹤0.01% 3509
2024
Q2
$904 Sell
21
-66
-76% -$2.9K ﹤0.01% 3488
2024
Q1
$3.87K Sell
87
-17
-16% -$775 ﹤0.01% 3224
2023
Q4
$4.78K Buy
+104
New +$4.42K ﹤0.01% 3131
2023
Q2
Sell
-13,736
Closed -$669K 3610
2023
Q1
$669K Sell
13,736
-342
-2% -$17.4K 0.01% 982
2022
Q4
$704K Buy
14,078
+680
+5% +$33.5K 0.02% 641
2022
Q3
$587K Buy
+13,398
New +$662K 0.01% 893

Other funds holding QGEN

NewEdge Advisors's QGEN Position: Q2 2026 in Review

NewEdge Advisors sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 19 shares — an estimated $761 sold.

NewEdge Advisors first reported a position in QGEN in Q3 2022 and held it in 9 quarters. The position peaked at $704K in Q4 2022. 243 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • NewEdge Advisors reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • NewEdge Advisors sold 19 Qiagen shares in Q2 2026, an estimated $761.
  • NewEdge Advisors first reported a position in Qiagen in Q3 2022 and held it in 9 quarters.
  • NewEdge Advisors's Qiagen position peaked at $704K in Q4 2022.
  • 243 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.